Pretty pathetic considering initial idea was to IPO in 6-8$ range raising 20 million in cash to fund operations & get MANF to clinic resulting in 10-12 OS shares w/ minimal to no dilution moving forward near term. Now its offer shares at 1.39 to pay salaries.